Nosocomial Pneumonia Clinical Trial
Official title:
Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
This is a retrospective, observational, non-interventional drug study using de-identified
data from two administrative claims datasets. The study design and analysis will reflect the
perspective of the commercially insured. The objectives of this study are twofold:
1. To compare the rates of re-hospitalization among patients treated with either linezolid
orally or IV, or vancomycin IV for complicated skin and skin structure infections
(cSSSI) or pneumonia hospitalization.
2. To compare the total direct medical costs of patients treated with linezolid orally or
IV, or vancomycin IV for cSSSI or pneumonia hospitalization.
A sampling method is not used in this study since it is a retrospective, non-interventional claims database analysis. Pre-specified inclusion/exclusion criteria and ICD-9, NDC, HCPC codes are applied to identify the study cohorts. ;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04488510 -
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
|
||
Completed |
NCT02598609 -
SEPREVEN: a Stepped-wedge Randomised Controlled Trial
|
N/A | |
Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
Completed |
NCT06162455 -
High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB
|
N/A | |
Terminated |
NCT01897792 -
Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma
|
Phase 2 | |
Recruiting |
NCT00842478 -
Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia
|
Phase 2/Phase 3 | |
Completed |
NCT00610324 -
Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients
|
Phase 4 | |
Completed |
NCT04279873 -
Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia
|
||
Completed |
NCT03303937 -
Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients
|
N/A | |
Recruiting |
NCT01796717 -
Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
|
Phase 2/Phase 3 | |
Recruiting |
NCT06170372 -
High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia
|
N/A | |
Completed |
NCT00829842 -
Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery
|
Phase 3 | |
Recruiting |
NCT06261827 -
High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB
|
N/A | |
Completed |
NCT05928208 -
The Role of Point-of-care Polymerase Chain Reaction in Managing Nosocomial Pneumonia
|
||
Completed |
NCT02793141 -
International Study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE)
|
||
Completed |
NCT00236834 -
A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization
|
Phase 3 | |
Not yet recruiting |
NCT06310941 -
Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
|
N/A | |
Completed |
NCT02413242 -
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
|
||
Recruiting |
NCT04223752 -
Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)
|
Phase 1 |